FDA grants EUA for AstraZeneca COVID-19 vaccine

Updated Thu, January 28, 2021 at 11:20 AM Published Thu, January 28, 2021 at 11:14 AM

The Philippine Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the AstraZeneca COVID-19 vaccine, its director general, Dr. Eric Domingo, announced on Thursday.

This makes AstraZeneca, a British pharmaceutical firm, the second company to secure an EUA in the Philippines after Pfizer BioNTech.

Dr. Domingo stated that the AstraZeneca vaccine, developed with Oxford University, has shown an efficacy rate of 70% after the first dose, which increases after a second dose depending on the interval.

He also mentioned that the vaccine is very effective in preventing severe COVID-19 infections, with initial data showing nearly 100% effectiveness in this regard, although more data is expected.

Domingo affirmed that all conditions for EUA are met and the benefits of using the vaccine outweigh the potential risks.

Topics in this story

Explore more stories about these topics.

COVID-19 Food and Drug Administration

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.